People who consume about 320 mg of magnesium per day from food are less likely to develop depression than those who consume less, with the protective effect leveling off at higher intakes.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review and meta-analysis of RCTs could determine whether magnesium supplementation causally reduces depression incidence or severity in at-risk populations.
A systematic review and meta-analysis of at least 10 double-blind RCTs involving adults with subclinical depressive symptoms or high risk (e.g., low magnesium, chronic illness), randomized to 320 mg/day oral magnesium citrate vs placebo for 12 weeks, with primary outcome being change in PHQ-9 score, secondary outcomes including serum magnesium levels and quality-of-life measures.
A large RCT could determine whether magnesium supplementation reduces the incidence or severity of depression in a defined population over time.
A multicenter, double-blind, placebo-controlled RCT with 800 adults aged 25-65 with low dietary magnesium intake (<250 mg/day) and elevated PHQ-9 scores (≥5), randomized to 320 mg/day magnesium citrate or placebo for 6 months, with primary outcome being incidence of major depressive episode (DSM-5 criteria) and secondary outcomes including PHQ-9, serum magnesium, and inflammatory markers.
A prospective cohort study could assess whether baseline magnesium intake predicts future depression diagnosis over time.
A prospective cohort study following 5,000 adults aged 20-70 without depression for 8 years, measuring dietary magnesium intake via repeated 7-day food records and serum magnesium at baseline and year 3, and tracking depression diagnosis via clinical interviews and validated scales, adjusting for socioeconomic status, physical activity, and comorbidities.
A cross-sectional study could identify whether individuals with depression have lower average magnesium intake or serum levels than controls.
A cross-sectional study comparing dietary magnesium intake (via food frequency questionnaire) and serum magnesium levels in 400 adults with diagnosed major depressive disorder and 400 age- and sex-matched controls without psychiatric diagnosis, controlling for medication use, alcohol intake, and BMI.
Case reports could document rare instances where magnesium supplementation led to rapid improvement in depressive symptoms in individuals with documented hypomagnesemia.
A case series of 15 adults with major depressive disorder and serum magnesium <0.7 mmol/L who received 320 mg/day magnesium citrate for 8 weeks, documenting changes in PHQ-9, serum magnesium, and sleep quality, with detailed dietary and medication logs.